Find out about the history of public health and the pressing needs for public health services today.

Tool may be more accurate than existing methods and was made possible through a cohort of tens of thousands of patients from different backgrounds around the world.

Multi-million dollar gift from The Wawa Foundation brings Coffee and Care Cart to CHOP’s second inpatient hospital, offering comfort to patients and families, while helping to expand Wawa Volunteer Services program.

Children’s Hospital of Philadelphia (CHOP) researcher Riccardo Gottardi, PhD has been named a “Young Innovator of Cellular and Molecular Bioengineering” by Cellular and Molecular Bioengineering, the official journal of the Biomedical Engineering Society.

“Nudges” from electronic health records could improve the implementation of tobacco use treatment almost three-fold over standard care.

CHOP has treated its 500th patient with CAR T-cell immunotherapy, a “living drug” that harnesses the power of a patient’s own immune system to fight cancer.

CHOP researchers have shown that NSAIDs disrupt epithelial cells in the colon and sensitize them to C. difficile toxins by perturbing cell mitochondria.

Children’s Hospital of Philadelphia (CHOP) has been recognized by the 2023 Disability Equality Index (DEI) as a leader in “Best Places to Work for Disability Inclusion.”

The Neurologic Infections Clinic at Children’s Hospital of Philadelphia (CHOP) was established to enhance clinical care for children with definite or suspected, acute and chronic, standard and emerging infections of the central nervous system. We combine pediatric neurology and pediatric infectious diseases expertise to optimize multidisciplinary evaluation, acute care and long-term management of these children. 

Agenesis of the corpus callosum (ACC) is one of the most common referrals seen in the prenatal period at the Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment (CFDT) at Children’s Hospital of Philadelphia (CHOP).